Tag Archives: mrk

Stock Movers: Why These 5 Top Stocks Are Rising Today

Here is why shares of biotech Gilead Sciences (GILD) and three four other highly rated stocks are rallying in heavy volume today. Gilead began running up in premarket trading after drug giant Merck (MRK) said Sunday it would not move forward with development of a drug combination aimed at shortening treatment time for hepatitis C, citing disappointing clinical data. The treatment would have used Gilead’s Sovaldi, but also would compete with the

Merck Down On Hepatitis C Data; Gilead Rises

Big pharma Merck (MRK) was down nearly 2% on the stock market today after the latest data from its hepatitis C pipeline underwhelmed the Street. On Sunday at the annual conference of the American Association for the Study of Liver Disease, Merck reported the much-anticipated interim data from its C-Swift trial , which analysts thought could challenge market leader Gilead Sciences (GILD) if it could show high cure rates at four weeks to six weeks,

Merck, Bristol, Arrowhead Prep Hepatitis Studies

Big pharma Merck affirmed Wednesday that it’ll present much-anticipated data from its hepatitis C program at next month’s American Association for the Study of Liver Diseases Liver Meeting, but investors will have to wait till the meeting itself to find out the actual data. Bristol-Myers Squibb (BMY) was more forthcoming, but its results failed to ignite the stock. Merck (MRK) said that it will present data from its phase-two C-Swift trial, which